Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population.

Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Therneau TM, Colby CL, Clark RJ, Mead GP, Kumar S, Melton LJ 3rd, Rajkumar SV.

Mayo Clin Proc. 2012 Jun;87(6):517-23. doi: 10.1016/j.mayocp.2012.03.009.

2.

Reply to "pediatric reference intervals for immunoglobulin G and its subclasses with Siemens immunonephelometric assays".

Parker AR, Hughes RG, Mead GP, Carr-Smith HD.

Clin Biochem. 2011 Jun;44(8-9):745-6. doi: 10.1016/j.clinbiochem.2011.01.013. Epub 2011 Feb 1. No abstract available.

PMID:
21291876
3.

Overestimation of serum kappa free light chain concentration by immunonephelometry.

Mead GP, Carr-Smith HD.

Clin Chem. 2010 Sep;56(9):1503-4; author reply 1504-5. doi: 10.1373/clinchem.2010.150490. Epub 2010 Jun 25. No abstract available.

4.

Frequency of altered monoclonal protein production at relapse of multiple myeloma.

Hobbs JA, Drayson MT, Sharp K, Harding S, Bradwell AR, Mead GP.

Br J Haematol. 2010 Feb;148(4):659-61. doi: 10.1111/j.1365-2141.2009.07952.x. Epub 2009 Oct 26. No abstract available.

PMID:
19863537
5.

Sensitivity of serum free light chain measurement of residual disease in multiple myeloma patients.

Mead GP, Drayson MT.

Blood. 2009 Aug 20;114(8):1717. doi: 10.1182/blood-2009-06-225854. No abstract available.

6.
7.

Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios.

Bradwell AR, Harding SJ, Fourrier NJ, Wallis GL, Drayson MT, Carr-Smith HD, Mead GP.

Clin Chem. 2009 Sep;55(9):1646-55. doi: 10.1373/clinchem.2009.123828. Epub 2009 Jul 17.

8.

Monoclonal vs polyclonal free light chain assays.

Legg A, Hobbs JA, Mead GP, Bradwell AR.

Am J Clin Pathol. 2009 Jun;131(6):901-2; author reply 902-3. doi: 10.1309/AJCPBWZD3EFWHNLL. No abstract available.

PMID:
19461100
9.

Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.

Hutchison CA, Harding S, Hewins P, Mead GP, Townsend J, Bradwell AR, Cockwell P.

Clin J Am Soc Nephrol. 2008 Nov;3(6):1684-90. doi: 10.2215/CJN.02290508.

10.

Free light chains.

Mead GP, Carr-Smith HD, Bradwell AR.

Ann Clin Biochem. 2008 Jul;45(Pt 4):444. doi: 10.1258/acb.2008.072541. No abstract available.

PMID:
18583638
11.

Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?

Hutchison CA, Cockwell P, Harding S, Mead GP, Bradwell AR, Barnett AH.

Expert Opin Ther Targets. 2008 Jun;12(6):667-76. doi: 10.1517/14728222.12.6.667 .

PMID:
18479214
12.

Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.

Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR.

J Am Soc Nephrol. 2007 Mar;18(3):886-95. Epub 2007 Jan 17.

13.

The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains.

Pratt G, Mead GP, Godfrey KR, Hu Y, Evans ND, Chappell MJ, Lovell R, Bradwell AR.

Leuk Lymphoma. 2006 Jan;47(1):21-8.

PMID:
16321823
14.

Serum free light chains for monitoring multiple myeloma.

Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR.

Br J Haematol. 2004 Aug;126(3):348-54.

PMID:
15257706
15.

Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma.

Betea D, Bradwell AR, Harvey TC, Mead GP, Schmidt-Gayk H, Ghaye B, Daly AF, Beckers A.

J Clin Endocrinol Metab. 2004 Jul;89(7):3413-20.

16.

Measurement of immunoglobulin free light chains in serum.

Mead GP, Drayson MT, Carr-Smith HD, Bradwell AR.

Clin Chem. 2003 Nov;49(11):1957-8; author reply 1958. No abstract available.

17.

Detection of Bence Jones myeloma and monitoring of myeloma chemotherapy using immunoassays specific for free immunoglobulin light chains.

Mead GP, Carr-Smith HD, Drayson MT, Bradwell AR.

Clin Lab. 2003;49(1-2):25-7. No abstract available.

PMID:
12593472
18.

Serum test for assessment of patients with Bence Jones myeloma.

Bradwell AR, Carr-Smith HD, Mead GP, Harvey TC, Drayson MT.

Lancet. 2003 Feb 8;361(9356):489-91.

PMID:
12583950
19.

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.

Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR.

Blood. 2001 May 1;97(9):2900-2.

PMID:
11313287
20.

Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R.

Clin Chem. 2001 Apr;47(4):673-80.

21.

Detection of Ki67 antigen by a new sheep polyclonal antiserum.

Reynolds GM, Rowlands DC, Mead GP.

J Clin Pathol. 1995 Dec;48(12):1138-40.

Supplemental Content

Support Center